Selected research
Industry Research
Genome Annotation Service Industry Research Report 2026
Market perspective
The global Genome Annotation Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Genome Annotation Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Genome Annotation Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Genome Annotation Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Genome Annotation Service include Charles River, Lexogen, Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp and Berry Genomics, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Genome Annotation Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Genome Annotation Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Genome Annotation Service Market by Company
Charles River
Lexogen
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Novogene
Genotypic Technology
Dna Link
Genome Annotation Service Segment by Type
RAST Tool Kit
Viral Genome ORF Reader
Genome Annotation Service Segment by Application
Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others
Genome Annotation Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genome Annotation Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Genome Annotation Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genome Annotation Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Genome Annotation Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- RAST Tool Kit
- Viral Genome ORF Reader
Applications
- Hospitals and Clinics
- Biopharma Companies
- Academic & Research Organizations
- Others
Companies covered
- Charles River
- Lexogen
- Eurofins Scientific
- Natera
- BGI
- Illumina
- Roche
- LabCorp
- Berry Genomics
- Brooks Life Sciences
- Macrogen
- Personalis
- Novogene
- Genotypic Technology
- Dna Link
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Genome Annotation Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 RAST Tool Kit
- 2.2.3 Viral Genome ORF Reader
- 2.3 Genome Annotation Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals and Clinics
- 2.3.3 Biopharma Companies
- 2.3.4 Academic & Research Organizations
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Genome Annotation Service Breakdown Data by Type
- 3.1 Global Genome Annotation Service Historic Market Size by Type (2021-2026)
- 3.2 Global Genome Annotation Service Forecasted Market Size by Type (2027-2032)
4 Genome Annotation Service Breakdown Data by Application
- 4.1 Global Genome Annotation Service Historic Market Size by Application (2021-2026)
- 4.2 Global Genome Annotation Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Genome Annotation Service Market Perspective (2021-2032)
- 5.2 Global Genome Annotation Service Growth Trends by Region
- 5.2.1 Global Genome Annotation Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Genome Annotation Service Historic Market Size by Region (2021-2026)
- 5.2.3 Genome Annotation Service Forecasted Market Size by Region (2027-2032)
- 5.3 Genome Annotation Service Market Dynamics
- 5.3.1 Genome Annotation Service Industry Trends
- 5.3.2 Genome Annotation Service Market Drivers
- 5.3.3 Genome Annotation Service Market Challenges
- 5.3.4 Genome Annotation Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Genome Annotation Service Players by Revenue
- 6.1.1 Global Top Genome Annotation Service Players by Revenue (2021-2026)
- 6.1.2 Global Genome Annotation Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Genome Annotation Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Genome Annotation Service Head Office and Area Served
- 6.4 Global Genome Annotation Service Players, Product Type & Application
- 6.5 Global Genome Annotation Service Manufacturers Established Date
- 6.6 Global Genome Annotation Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Genome Annotation Service Market Size (2021-2032)
- 7.2 North America Genome Annotation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Genome Annotation Service Market Size by Country (2021-2026)
- 7.4 North America Genome Annotation Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Genome Annotation Service Market Size (2021-2032)
- 8.2 Europe Genome Annotation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Genome Annotation Service Market Size by Country (2021-2026)
- 8.4 Europe Genome Annotation Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Genome Annotation Service Market Size (2021-2032)
- 9.2 Asia-Pacific Genome Annotation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Genome Annotation Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Genome Annotation Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Genome Annotation Service Market Size (2021-2032)
- 10.2 South America Genome Annotation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Genome Annotation Service Market Size by Country (2021-2026)
- 10.4 South America Genome Annotation Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Genome Annotation Service Market Size (2021-2032)
- 11.2 Middle East & Africa Genome Annotation Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Genome Annotation Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Genome Annotation Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Charles River
- 12.1.1 Charles River Company Information
- 12.1.2 Charles River Business Overview
- 12.1.3 Charles River Revenue in Genome Annotation Service Business (2021-2026)
- 12.1.4 Charles River Genome Annotation Service Product Portfolio
- 12.1.5 Charles River Recent Developments
- 12.2 Lexogen
- 12.2.1 Lexogen Company Information
- 12.2.2 Lexogen Business Overview
- 12.2.3 Lexogen Revenue in Genome Annotation Service Business (2021-2026)
- 12.2.4 Lexogen Genome Annotation Service Product Portfolio
- 12.2.5 Lexogen Recent Developments
- 12.3 Eurofins Scientific
- 12.3.1 Eurofins Scientific Company Information
- 12.3.2 Eurofins Scientific Business Overview
- 12.3.3 Eurofins Scientific Revenue in Genome Annotation Service Business (2021-2026)
- 12.3.4 Eurofins Scientific Genome Annotation Service Product Portfolio
- 12.3.5 Eurofins Scientific Recent Developments
- 12.4 Natera
- 12.4.1 Natera Company Information
- 12.4.2 Natera Business Overview
- 12.4.3 Natera Revenue in Genome Annotation Service Business (2021-2026)
- 12.4.4 Natera Genome Annotation Service Product Portfolio
- 12.4.5 Natera Recent Developments
- 12.5 BGI
- 12.5.1 BGI Company Information
- 12.5.2 BGI Business Overview
- 12.5.3 BGI Revenue in Genome Annotation Service Business (2021-2026)
- 12.5.4 BGI Genome Annotation Service Product Portfolio
- 12.5.5 BGI Recent Developments
- 12.6 Illumina
- 12.6.1 Illumina Company Information
- 12.6.2 Illumina Business Overview
- 12.6.3 Illumina Revenue in Genome Annotation Service Business (2021-2026)
- 12.6.4 Illumina Genome Annotation Service Product Portfolio
- 12.6.5 Illumina Recent Developments
- 12.7 Roche
- 12.7.1 Roche Company Information
- 12.7.2 Roche Business Overview
- 12.7.3 Roche Revenue in Genome Annotation Service Business (2021-2026)
- 12.7.4 Roche Genome Annotation Service Product Portfolio
- 12.7.5 Roche Recent Developments
- 12.8 LabCorp
- 12.8.1 LabCorp Company Information
- 12.8.2 LabCorp Business Overview
- 12.8.3 LabCorp Revenue in Genome Annotation Service Business (2021-2026)
- 12.8.4 LabCorp Genome Annotation Service Product Portfolio
- 12.8.5 LabCorp Recent Developments
- 12.9 Berry Genomics
- 12.9.1 Berry Genomics Company Information
- 12.9.2 Berry Genomics Business Overview
- 12.9.3 Berry Genomics Revenue in Genome Annotation Service Business (2021-2026)
- 12.9.4 Berry Genomics Genome Annotation Service Product Portfolio
- 12.9.5 Berry Genomics Recent Developments
- 12.10 Brooks Life Sciences
- 12.10.1 Brooks Life Sciences Company Information
- 12.10.2 Brooks Life Sciences Business Overview
- 12.10.3 Brooks Life Sciences Revenue in Genome Annotation Service Business (2021-2026)
- 12.10.4 Brooks Life Sciences Genome Annotation Service Product Portfolio
- 12.10.5 Brooks Life Sciences Recent Developments
- 12.11 Macrogen
- 12.11.1 Macrogen Company Information
- 12.11.2 Macrogen Business Overview
- 12.11.3 Macrogen Revenue in Genome Annotation Service Business (2021-2026)
- 12.11.4 Macrogen Genome Annotation Service Product Portfolio
- 12.11.5 Macrogen Recent Developments
- 12.12 Personalis
- 12.12.1 Personalis Company Information
- 12.12.2 Personalis Business Overview
- 12.12.3 Personalis Revenue in Genome Annotation Service Business (2021-2026)
- 12.12.4 Personalis Genome Annotation Service Product Portfolio
- 12.12.5 Personalis Recent Developments
- 12.13 Novogene
- 12.13.1 Novogene Company Information
- 12.13.2 Novogene Business Overview
- 12.13.3 Novogene Revenue in Genome Annotation Service Business (2021-2026)
- 12.13.4 Novogene Genome Annotation Service Product Portfolio
- 12.13.5 Novogene Recent Developments
- 12.14 Genotypic Technology
- 12.14.1 Genotypic Technology Company Information
- 12.14.2 Genotypic Technology Business Overview
- 12.14.3 Genotypic Technology Revenue in Genome Annotation Service Business (2021-2026)
- 12.14.4 Genotypic Technology Genome Annotation Service Product Portfolio
- 12.14.5 Genotypic Technology Recent Developments
- 12.15 Dna Link
- 12.15.1 Dna Link Company Information
- 12.15.2 Dna Link Business Overview
- 12.15.3 Dna Link Revenue in Genome Annotation Service Business (2021-2026)
- 12.15.4 Dna Link Genome Annotation Service Product Portfolio
- 12.15.5 Dna Link Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst